Tau pathology in neurodegenerative diseases like AD spectrum triggers a cascade of neuroinflammatory responses in the brain, involving the activation of microglia and astrocytes in response to abnormal tau aggregates [79–83]. This evidence concerns the gene MAPT and neurodegenerative disease.